Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

AstraZeneca PLC Eases Its Migraine With $302 Million Sale

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-astrazeneca.jpg" NAME"AstraZeneca PLC Eases Its Migraine With $302 Million Sale" ALT"AstraZeneca PLC Eases Its Migraine With $302 Million Sale"June 7, 2017By Alex Keown, BioSpace.com Breaking News StaffLONDON... Source: BioSpace

Continue ReadingAstraZeneca PLC Eases Its Migraine With $302 Million Sale

<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co.

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-roivant-vivek-ramaswamy.jpg" NAME"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co." ALT"Ramaswamy Launches Another New Biotech to Work on Phase III-Ready Drug From Merck…

Continue Reading<b>Ramaswamy</b> Launches Another New Biotech to Work on Phase III-Ready Drug From Merck & Co.